Your NEJM Group Today: Summative vs. Formative Assessment, Ibuprofen & UTI, California Reproductive Endocrinologist Opportunity — Physician’s First Watch

Medical News |
February 12, 2016

Your NEJM Group Today: Summative vs. Formative Assessment, Ibuprofen & UTI, California Reproductive Endocrinologist Opportunity

By the Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Knowledge+ Blog: This week, bloggers consider summative vs. formative assessment, the strengths and weaknesses of each, and why this is important to physicians.

NEJM Journal Watch General Medicine: Using ibuprofen as the initial treatment for women with suspected uncomplicated UTI limits antibiotic use and late recurrence but prolongs symptoms.

NEJM CareerCenter: Palo Alto Medical Foundation in California is seeking a compassionate fertility and reproductive endocrinologist to join its medical group.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
Last load event
Format: 2016-06-26 21:59:47
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.